Differential expression patterns of Toll Like Receptors and Interleukin-37 between calcific aortic and mitral valve

Alkistis Kapelouzou1, Christos Kontogiannis2, Diamantis I Tsilimigras2

  • 1Centre for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.

Cytokine
|February 5, 2019
PubMed

Insights

Aortic and mitral valve calcification differ due to inflammation. Aortic valves show lower Interleukin-37 (IL-37) and higher Toll Like Receptors (TLR) than mitral valves, impacting calcification progression.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Pathology

Background:

  • Calcific valve disease involves inflammation, with Toll Like Receptors (TLR) and Interleukin-37 (IL-37) pathways implicated.
  • Significant differences exist in calcification progression between aortic and mitral valves.

Purpose of the Study:

  • To investigate the role of TLR-mediated inflammation and IL-37 pathway expression in aortic and mitral valve calcification.
  • To compare the expression of inflammatory markers and calcification biomarkers between stenotic aortic and mitral valves.

Main Methods:

  • Histological, immunohistochemistry, and morphometric analysis of 120 stenotic valve cusps (60 aortic, 60 mitral).
  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR) to assess mRNA levels of target genes.

Main Results:

  • Mitral valve leaflets (MVL) showed increased anti-inflammatory IL-37 levels compared to aortic valve cusps (AVCu).
  • Toll Like Receptors (TLR) levels were decreased in MVL compared to AVCu.
  • Osteopontin was the only calcification biomarker that differed between AVCu and MVL.

Conclusions:

  • Stenotic aortic valves exhibit lower IL-37 and higher TLR levels than stenotic mitral valves, indicating distinct pro-calcification and pro-inflammatory profiles.
  • These differential inflammatory profiles may explain the higher incidence of aortic valve calcification and suggest potential therapeutic targets.
Abstract

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
491
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
548
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
357
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
11.9K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
592
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
521